Skip to content

Effect of a freezing method on bleeding severity in patients undergoing bronchoscopic biopsy.

Effect of Pre-Biopsy Cryo-application on Bleeding Severity during Flexible Bronchoscopic Forceps Biopsy of Endobronchial Lesions: The CRYOCON Randomized Clinical Trial - CRYOCON

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/04/065466
Enrollment
180
Registered
2024-04-09
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J980- Diseases of bronchus, not elsewhere classified

Interventions

Intervention1: Cryoprobe application prior to biopsy of target lesion: One-time Control Intervention1: Conventional forceps biopsy of target lesion (without prior cryoprobe application): One-time

Sponsors

Mayank Mishra
Lead Sponsor
Girish Sindhwani
Collaborator
Nilotpal Chowdhury
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Adults more than or equal to 18 years of age undergoing flexible bronchoscopic forceps biopsy of a definite exophytic / definite infiltrative endobronchial lesion under local or general anesthesia.

Exclusion criteria

Exclusion criteria: Mucosal irregularities, hypervascular lesions like carcinoid. No endobronchial lesion found on flexible bronchoscopy or lesion deemed unamenable to biopsy by the operator. Not giving informed consent for the procedure. Uncooperative patient. Pre-procedural hypoxemia. Uncontrolled baseline hypertension. Symptomatic coronary artery disease or high cardiac risk for procedure. On anticoagulants. Uncorrectable coagulopathy. Pacemaker or implantable cardioverter defibrillator in situ.

Design outcomes

Primary

MeasureTime frame
Severity of bleeding after flexible bronchoscopic forceps biopsy of endobronchial lesion with or without prior application of cryoprobe to the lesionTimepoint: 0 days

Secondary

MeasureTime frame
Presence of artefacts/tissue damage in the biopsy specimenTimepoint: 0 days;Interpretability of biopsy specimenTimepoint: 0 days;Diagnostic yield on histopathological examinationTimepoint: 0 days

Countries

India

Contacts

Public ContactMayank Mishra

All India Institute of Medical Sciences, Rishikesh

virgodrmayank@gmail.com01352462984

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 9, 2026